Evidence map›Paper›PMID 23202270›Full record

ArticleNature immunology2013

Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells.

Nadia R Cohen, Patrick J Brennan, Tal Shay, Gerald F Watts, Manfred Brigl, Joonsoo Kang, Michael B Brenner, ImmGen Project Consortium

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 128 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy.Clinical reviews in allergy & immunology · 2024
    Review
  10. Article
  11. Article
  12. Innate Immunity in Autoimmune Thyroid Disease during Pregnancy.International journal of molecular sciences · 2023
    Review
  13. Invariant natural killer T cells in lung diseases.Experimental & molecular medicine · 2023
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Nadia R CohenDepartment of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Patrick J Brennan
Tal Shay
Gerald F Watts
Manfred Brigl
Joonsoo Kang
Michael B Brenner
ImmGen Project Consortium
Harvard University · USBrigham and Women's Hospital · USBroad Institute · USUniversity of Massachusetts Chan Medical School · US

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
ImmGen: Gene Expression and Regulation in Immune CellsR24AI072073 · NIAID · JOSLIN DIABETES CENTER · PI CHRISTOPHE O. BENOIST · 2007 to 2026
$28.5M
Research BaseP30DK063720 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GERMAN, MICHAEL S · 2003 to 2019
$21.8M
IMMUNOLOGIC BASIS OF RESISTANCE AND HYPERSENSITIVITYT32AI007306 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Nora Amanda Barrett, Joshua A Boyce · 1985 to 2026
$12.2M
T LYMPOHOCYTE RECOGNITIONR01AI028973 · NIAID · DANA-FARBER CANCER INSTITUTE · PI BRENNER, MICHAEL B. · 1990 to 2014
$4.5M
CD1d-restricted T Cell Self-antigens and InfectionR01AI063428 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B. · 2005 to 2015
$3.9M
NIAID NIH HHS R01 AI028973NIAID NIH HHS R01 AI063428NIAID NIH HHS R01AI063428NIAID NIH HHS R24 AI072073NIAID NIH HHS R24AI072073NIAID NIH HHS T32 AI007306NIAID NIH HHS T32AI007306NIDDK NIH HHS P30 DK026743NIDDK NIH HHS P30 DK063720
6 · The paper itself

Abstract

Invariant natural killer T cells (iNKT cells) are innate-like T lymphocytes that act as critical regulators of the immune response. To better characterize this population, we profiled gene expression in iNKT cells during ontogeny and in peripheral subsets as part of the Immunological Genome Project. High-resolution comparative transcriptional analyses defined developmental and subset-specific programs of gene expression by iNKT cells. In addition, we found that iNKT cells shared an extensive transcriptional program with NK cells, similar in magnitude to that shared with major histocompatibility complex (MHC)-restricted T cells. Notably, the program shared by NK cells and iNKT cells also operated constitutively in γδ T cells and in adaptive T cells after activation. Together our findings highlight a core effector program regulated distinctly in innate and adaptive lymphocytes.

Indexed as

TranscriptomeAdaptive ImmunityAnimalsCell DifferentiationCell LineageGenome, HumanHumansImmunity, InnateImmunologic MemoryMiceMicroarray AnalysisNatural Killer T-CellsThymus GlandT-Lymphocyte Subsets

Identifiers

PMID23202270
PMCPMC3764492
OpenAlexW2113912833

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.